Investor Presentation under Regulation 30 read with Schedule III of SEBI(LODR), 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shanmuga Hospital, a multi-specialty hospital based in Salem, Tamil Nadu, filed its H1 FY26 investor presentation with BSE. For H1 FY26, revenue stood at ₹24.72 Cr (roughly flat versus ₹24.83 Cr in H1 FY25), while profit after tax (PAT) declined to ₹2.01 Cr from ₹2.39 Cr in H1 FY25. EBITDA was ₹4.61 Cr with an improved margin of 18.73%, versus 13.05% reported for FY25 (full year). Operationally, the hospital ran 120 beds at 47.5% occupancy, served 23,131 outpatients and 2,141 inpatients, and performed 40 robotic surgeries. The company outlined growth plans including adding 50 inpatient beds, launching a renal transplant program, a new Nephro Care Center, an upgraded OPD facility, and a digital health app. Promoters hold 72.1% of shares; stock trades at ₹49.5 with a market cap of ₹67.38 Cr.
Mixed signals for shareholders: revenue stayed flat and PAT dipped year-on-year, but EBITDA margin expanded meaningfully, suggesting better cost efficiency. Forward-looking plans (bed expansion, transplant services, digital integration) could support future growth, though the small float, low occupancy of 47.5%, and modest scale mean execution will be closely watched.